Sanjeeb Kumar Sahoo

Professional Experience: Jul. 2005- Continuing Scientist, Institute of Life Sciences, Bhubaneswar, India Jul. 2004 -Jun. 2005 Research Associate, Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA Sep. 2001-Jun. 2004 Postdoctoral Research Associate, Department of Pharmaceutical Sciences, University of Nebraska Medical Center. Omaha, NE, USA. Aug.1999 - Aug. 2001 Postdoctoral Research Fellow, Japan Society for Promotion of Science (JSPS) Postdoctoral fellow with Prof. Hiroshi Maeda at Department of Microbiology, Kumamoto University School of Medicine, Kumamoto, Japan. Mar. 1999 – Aug. 1999 Scientist, Dabur Research Foundation. Dabur India Ltd., India. Jan. 1998 – Mar.1998 Research Fellow, with Prof. S.S. Davis, Department of Pharmaceutical Sciences, University of Nottingham, Nottingham, U. K. Distinctions/ Fellowships/ Awards and Achievements • Among Top 2% Scientists in world ranking brought out by Stanford University, 2020 • Dr. Sahoo’s name has figured in the list of influential researchers of the world released by a US-based firm Clarivate Analytics on the basis of Citations in the year 2019. Only 10 scientists, including Dr. Sahoo from India, made it to the list of 4000 researchers of the world. • Awarded “SAMANTA CHANDRASEKHARA AWARD”, Orissa Bigyan Academy (2000) • Awarded International Fellowship for Young Biomedical Scientists from ICMR for four months in 2008 to work at Creighton University, Omaha, Nebraska, USA • Awarded Postdoctoral fellowship from the American Heart Association (AHA), United States of America (2002-2004). • Awarded Japanese Society for Promotion of Science (JSPS) postdoctoral fellowship from the Government of Japan (1999-2001). • U.S. Patent No-5, 874,111 “Process for the preparation of highly monodispersed hydrophilic polymeric nanoparticles”. • U. S. Patent No-6, 365, 91 “Formulation of Paclitaxel, its derivatives or its analogs entrapped in to nanoparticles of polymeric micelles, process for preparing same and the use there of. The patented formulation is under clinical trial by Dabur India Ltd, New Delhi, India. • Awarded travel grants from the School of Pharmacy, University of London to attend the 3rd International symposium on Polymer Therapeutics from Laboratory to Clinical Practice, January 7th –9th 1998, School of Pharmacy, University of London, UK. • Secured (84.07 percentile) All India Graduate Aptitude Test in Engineering (GATE) in 1996 • Awarded Junior Research Fellowship (JRF, 1996-98) University Grant Commission, Government of India. • Awarded Senior Research Fellowship (SRF, 1998-1999), University Grant Commission, Government of India. • Funding: Postdoctoral fellowship from American Heart Association (Heartland affiliated) in the project “Micellar nanosystem for localized arterial delivery of rapamycin to inhibit Restenosis” (July 2002-June 2004, $ 86,879). Areas of research interest: • Broad area of Nanobiotechnology. • Formulation design, development and evaluation of biodegradable nanoparticle based drug and gene delivery systems for treatment of cancer. • Improvement in drug delivery formulations using macromolecular conjugation of anticancer drugs and proteins. Targeting of drug loaded particulate system for enhanced therapeutic action to specific sites.